Patents by Inventor David Carroll

David Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150114652
    Abstract: The disclosure contained herein describes systems, units, and methods usable to stimulate a formation including a pump usable to pressurize fluid, an electric-powered driver in communication with and actuating the pump, and an electrical power source in communication with and powering the electric-powered driver. The electrical power source can include on-site generators and/or grid power sources, and transformers can be used to alter the voltage received to a voltage suitable for powering the electric-powered driver. Air moving devices associated with the electric-powered driver can be used to provide air proximate to the pump to disperse gasses. In combination with fluid supply and/or proppant addition subsystems, the pump can be used to fracture a formation.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 30, 2015
    Inventors: Robert S. Lestz, John F. Thrash, Audis C. Byrd, James H. Junkins, Norman S. Myers, David A. Carroll
  • Publication number: 20150119755
    Abstract: The present invention provides a skin surface sampling device in which a supply tube and a recovery tube are housed in an elongated hand-holdable tubular sleeve, the sleeve having upper and lower ends positioned along a longitudinal axis and the lower end being provided with a sampling head; in which: the supply tube is adapted to convey liquid from a liquid source to the sampling head; the recovery tube is adapted to convey liquid from the sampling head to a liquid collection vessel; the sampling head has a planar surface adapted for application to the surface of the skin to form a contact therewith during sampling; the planar surface has a liquid entry port adapted for liquid communication with the supply tube and a liquid exit port adapted for liquid communication with the recovery tube; and characterised in that: the liquid entry port and the liquid exit port are connected via a guide channel which is adapted to guide liquid from the liquid entry port, along the surface of the skin for the elution of mate
    Type: Application
    Filed: April 15, 2013
    Publication date: April 30, 2015
    Applicant: Conopco, Inc. d/b/a UNILEVER
    Inventors: Corrinne Burns, Peter David Carroll, Pareenkumar Patel, Svetlana Riazanskaia, Charles Lawrence Paul Thomas
  • Publication number: 20150113576
    Abstract: Certain aspects of an apparatus and method for Internet protocol (IP) video signal synchronization may include a server or switching center. The method for synchronized transmission of content may include receiving a plurality of content streams and a request to switch the transmission of content. The plurality of content streams may be received from a plurality of sources. The request to switch may switch the transmission of content from a first content stream to a second content stream of the received plurality of content streams. A time delay may be determined to be added to the transmission of content to compensate for a propagation delay of the received request and a processing delay to process the received request.
    Type: Application
    Filed: October 23, 2013
    Publication date: April 23, 2015
    Inventor: David Carroll
  • Patent number: 8987303
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: March 24, 2015
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Patent number: 8980921
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: March 17, 2015
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Patent number: 8962643
    Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: February 24, 2015
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Ankush Argade, Kin Tso, Sambaiah Thota, David Carroll, Arvinder Sran, Robin Cooper, Rajinder Singh, Somasekhar Bhamidipati, Vanessa Taylor, Esteban Masuda
  • Patent number: 8943329
    Abstract: A method and apparatus are disclosed for sharing an integrity security module in a dual-environment computing device. The apparatus include an integrity security module, one or more processors, a detection module and a regeneration module. The one or more processors may have access to the integrity security module and may operate in two distinct operating environments of a dual-environment computing device. The detection module may detect, during an initialization sequence, a power state transition of an operating environment of the dual-environment computing device. The regeneration module may regenerate one or more integrity values from a stored integrity metric log in response to detecting the power state transition of the operating environment of the dual-environment computing device.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: January 27, 2015
    Assignee: Lenovo (Singapore) Pte. Ltd.
    Inventors: David Carroll Challener, Daryl C. Cromer, Howard J. Locker, Randall Scott Springfield
  • Publication number: 20150011002
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
    Type: Application
    Filed: July 7, 2014
    Publication date: January 8, 2015
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • Publication number: 20140378429
    Abstract: The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) (The chemical formulas should be inserted here) in which the variables are as described herein.
    Type: Application
    Filed: January 31, 2013
    Publication date: December 25, 2014
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, David Carroll, Simon Shaw, Hitoshi Yasumichi
  • Patent number: 8884957
    Abstract: Disclosed herein methods, apparatuses, and systems for performing graphics processing. In this regard, a processing unit includes a tessellation module and a connectivity module. The tessellation module is configured to sequentially tessellate portions of a geometric shape to provide a series of tessellation points for the geometric shape. The connectivity module is configured to connect one or more groups of the tessellation points into one or more primitives in an order in which the series of tessellation points is provided.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: November 11, 2014
    Assignee: Advanced Micro Devices, Inc.
    Inventors: Vineet Goel, Jason David Carroll, Brian Buchner, Mangesh Nijasure
  • Publication number: 20140315884
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Application
    Filed: July 8, 2014
    Publication date: October 23, 2014
    Applicant: RIGEL PHARMACEUTICALS, INC.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Publication number: 20140314785
    Abstract: The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
    Type: Application
    Filed: June 25, 2014
    Publication date: October 23, 2014
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Sambaiah Thota, David Carroll, Ankush Argade, Kin Tso, Arvinder Sran, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Venessa Taylor, Robin Cooper, Rajinder Singh, Brian Wong
  • Patent number: 8854374
    Abstract: Methods, systems, and computer readable media embodiments are disclosed for generating primitives in a grid. Embodiments include generating a set of vertices in a section of the grid, selecting one or more vertices in the set of vertices in an order based on a proximity of the vertices to a boundary edge of the grid, and generating primitives based on the order of the selected vertices.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: October 7, 2014
    Assignee: Advanced Micro Devices, Inc.
    Inventors: Todd Martin, Mangesh Nijasure, Vineet Goel, Jason David Carroll
  • Patent number: 8815848
    Abstract: The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: August 26, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Sambaiah Thota, David Carroll, Ankush Argade, Kin Tso, Arvinder Sran, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Vanessa Taylor, Robin Cooper, Rajinder Singh, Brian Wong
  • Publication number: 20140234333
    Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.
    Type: Application
    Filed: April 8, 2014
    Publication date: August 21, 2014
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Ankush Argade, Sambaiah Thota, David Carroll, Arvinder Sran, Robin Cooper, Rajinder Singh, Kin Tso, Somasekhar Bhamidipati
  • Patent number: 8809370
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: August 19, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Patent number: 8809341
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: August 19, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • Publication number: 20140222790
    Abstract: Software code changes are facilitated by receiving as input a user query specifying a search term and automatically generating a ranked list of connected call trees based on the search term. Each connected call tree identifies subroutines that contain an identifier matching at least part of the search term or that are linked to a subroutine that contains an identifier matching at least part of the search term. The ranked list of connected call trees is displayed as a diagram.
    Type: Application
    Filed: February 6, 2013
    Publication date: August 7, 2014
    Inventors: David Carroll Shepherd, Brian P. Robinson
  • Patent number: 8791136
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: July 29, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Patent number: 8729087
    Abstract: The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: May 20, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Ankush Argade, Sambaiah Thota, David Carroll, Arvinder Sran, Robin Cooper, Rajinder Singh, Kin Tso, Somasekhar Bhamidipati